RCMI Coordinating Center (RCMI CC) Header Logo

Charu Gandotra

Concepts (51)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
4
2025
302
0.970
 Why?
Spironolactone
1
2021
36
0.690
 Why?
Gastric Bypass
1
2021
22
0.670
 Why?
Bariatric Surgery
1
2021
23
0.670
 Why?
Weight Loss
1
2021
137
0.630
 Why?
Antihypertensive Agents
1
2021
287
0.560
 Why?
Hypertension
2
2021
835
0.520
 Why?
Obesity
1
2021
1151
0.370
 Why?
Hypoglycemic Agents
2
2022
184
0.270
 Why?
Clinical Trials as Topic
2
2025
259
0.240
 Why?
United States Food and Drug Administration
2
2024
29
0.230
 Why?
Treatment Outcome
4
2025
1604
0.230
 Why?
Leuprolide
1
2021
8
0.180
 Why?
Biphenyl Compounds
1
2021
53
0.180
 Why?
Diabetes Mellitus, Type 2
2
2022
760
0.180
 Why?
Benzimidazoles
1
2021
43
0.180
 Why?
Metformin
1
2022
75
0.180
 Why?
Tetrazoles
1
2021
46
0.170
 Why?
Research Design
1
2023
385
0.170
 Why?
Oligopeptides
1
2021
109
0.170
 Why?
Antineoplastic Agents, Hormonal
1
2021
47
0.170
 Why?
Stroke Volume
1
2021
122
0.170
 Why?
Ventricular Function, Left
1
2021
114
0.170
 Why?
Myocardial Infarction
1
2023
247
0.160
 Why?
United States
4
2024
5205
0.150
 Why?
Retrospective Studies
2
2022
2544
0.130
 Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2016
5
0.120
 Why?
Humans
9
2025
43102
0.120
 Why?
Data Interpretation, Statistical
1
2016
125
0.120
 Why?
Risk Assessment
1
2016
863
0.100
 Why?
Prostatic Neoplasms
1
2021
1092
0.090
 Why?
Randomized Controlled Trials as Topic
2
2023
375
0.090
 Why?
Adult
2
2022
13872
0.070
 Why?
Cardiovascular Agents
1
2024
24
0.050
 Why?
Male
2
2021
23409
0.050
 Why?
Female
2
2021
24698
0.050
 Why?
Sulfonylurea Compounds
1
2022
17
0.050
 Why?
Drug Therapy, Combination
1
2022
234
0.050
 Why?
Renin-Angiotensin System
1
2021
48
0.040
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2021
78
0.040
 Why?
Blood Glucose
1
2022
389
0.040
 Why?
Longitudinal Studies
1
2023
1063
0.040
 Why?
Aged
2
2021
8214
0.040
 Why?
Medicare
1
2021
332
0.040
 Why?
Case-Control Studies
1
2021
1285
0.030
 Why?
Prospective Studies
1
2022
1600
0.030
 Why?
Hospitalization
1
2021
485
0.030
 Why?
Cohort Studies
1
2021
1759
0.030
 Why?
Review Literature as Topic
1
2016
9
0.030
 Why?
Meta-Analysis as Topic
1
2016
35
0.030
 Why?
Aged, 80 and over
1
2021
2853
0.030
 Why?
Gandotra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (51)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support